WebEX-10.9 7 d523612dex109.htm EX-10.9 EX-10.9 . Exhibit 10.9 . EVOKE PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY . Non-employee members of the board of directors (the “Board”) of Evoke Pharma, Inc. (the “Company”) shall be eligible to receive cash and equity compensation commencing on the date immediately preceding … WebFeb 9, 2024 · Evoke Pharma finally received FDA approval for Gimoti, a nasal formulation of a generic GI drug, in June 2024 and launched the drug in October 2024.
Evoke Pharma Announces Positive Findings from
WebNov 10, 2024 · Evoke Pharma, Inc. (NASDAQ:NASDAQ:EVOK) Q3 2024 Results Earnings Conference Call November 10, 2024 4:30 PM ETCompany ParticipantsDaniel Kontoh-Boateng - Investor Relations, DKB... WebMar 15, 2024 · About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic … dhs ogle county il
Gastroparesis Market Report 2032: Epidemiology Data
WebApr 26, 2024 · About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The … WebApr 12, 2024 · I spent five and a half years working in the charity sector on clients ranging from animal rescue to human rights. Then last year, I joined Evoke Mind+Matter in the … WebSep 5, 2024 · About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The Company is developing Gimoti, a ... dhs okc commerce st